Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer's Glucometer Dex

This article was originally published in The Gray Sheet

Executive Summary

U.S. launch of the home blood glucose monitoring system is expected in the first quarter of 1999, according to the company. "The Gray Sheet" (April 27, p. 10) had reported that the product would be introduced in the third quarter of 1998. Bayer will continue marketing its Glucometer Encore and Glucometer Elite systems following the launch of the Dex. The firm does not plan to release a Dex product for point-of-care testing
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010001

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel